Related Experiment Video
Updated: Oct 20, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
Arsene Zongo1,2, Cerina Lee3, Jason R B Dyck4
1Faculty of Pharmacy, Université Laval, Quebec City, QC, Canada. arsene.zongo@pha.ulaval.ca.
Insights
Medical cannabis authorization is linked to a higher risk of emergency visits and hospitalizations for cardiovascular events like stroke and acute coronary syndrome. This increased risk was observed in a Canadian study, particularly among males.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Therapeutic cannabis use is rising, but its cardiovascular safety remains under-researched.
- Concerns exist regarding the potential health risks associated with medical cannabis.
- Understanding the cardiovascular implications is crucial for patient safety.
Purpose of the Study:
- To evaluate the association between medical cannabis authorization and cardiovascular emergency department visits or hospitalizations.
- To assess the risk of acute coronary syndrome (ACS) and stroke in patients using medical cannabis.
- To compare cardiovascular event rates between authorized medical cannabis users and matched controls.
Main Methods:
- A longitudinal cohort study design was employed in Ontario, Canada (2014-2017).
- 18,653 medical cannabis patients were matched with 51,243 population-based controls.
- Conditional Cox proportional hazards regression analyzed the risk of cardiovascular events.
Main Results:
- Medical cannabis authorization was associated with a 44% increased risk of emergency visits/hospitalization for ACS or stroke (aHR 1.44).
- The risk was more pronounced in males (aHR 1.77) compared to females.
- A significant increase in overall cardiovascular events was also observed (aHR 1.47).
Conclusions:
- Medical cannabis authorization is associated with an elevated risk of cardiovascular events, including ACS and stroke.
- Healthcare providers should consider these cardiovascular risks when authorizing medical cannabis.
- Further research is needed to elucidate the mechanisms behind this association.
Background:
Cannabis is increasingly used for therapeutic purpose. However, its safety profile is not well known. This study assessed the risk of cardiovascular-related emergency department (ED) visit and hospitalization in adult patients authorized to use medical cannabis in Ontario, Canada from 2014 to 2017.
Methods:
This is a longitudinal cohort study of patients who received medical cannabis authorization and followed-up in cannabis clinics, matched to population-based controls. The primary outcome was an ED visit or hospitalization for acute coronary syndrome (ACS) or stroke; and secondary outcome was for any cardiovascular event. Conditional Cox proportional hazards regression was used to assess the association between cannabis authorization and risk.
Results:
18,653 cannabis patients were matched to 51,243 controls. During a median follow-up of 242 days, the incidence rates for ACS or stroke were 7.19/1000 person-years and 5.67/1000 person-years in the cannabis and controls group, respectively- adjusted hazard ratio (aHR) of 1.44 (95% CI 1.08-1.93). When stratified by sex, the association was only statistically significant among males: aHR 1.77 (1.23-2.56). For the secondary outcome (any CV events), the aHR was 1.47 (1.26-1.72). The aHR among males and females were 1.52 (1.24-1.86) and 1.41 (1.11-1.79), respectively. Tested interaction between cannabis authorization and sex was not significant (p > 0.05).
Conclusions:
Medical cannabis authorization was associated with an increased risk of ED visits or hospitalization for CV events including stroke and ACS.
Related Concept Videos
Longitudinal Studies
Longitudinal Research
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Imaging Studies for Cardiovascular System IV: CMRI
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction

